Levodopa Slows Progression of Parkinson’s Disease. External Validation by Clinical Trial Simulation

Author： Chan Phylinda   Nutt John   Holford Nicholas  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.24, Iss.4, 2007-04, pp. : 791-802

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Levodopa/carbidopa and Parkinson's disease progression

By  

Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Motor complications, levodopa metabolism and progression of Parkinson's disease

By Müüller Thomas  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 7, 2011-07 ,pp. : 847-855

Informa Healthcare

Access to resources Recommend Favorite

Alternatives to Levodopa in the Initial Treatment of Early Parkinson’s Disease

By Lees Andrew  

Drugs & Aging, Vol. 22, Iss. 9, 2005-01 ,pp. : 731-740

Adis International

Access to resources Recommend Favorite

Levodopa-Induced Response Fluctuations in Patients with Parkinson’s Disease: Strategies for Management

By van Laar T.  

CNS Drugs, Vol. 17, Iss. 7, 2003-01 ,pp. : 475-489

Adis International

Access to resources Recommend Favorite

The levodopa wearing-off phenomenon in Parkinson’s disease: pharmacokinetic considerations

By Stocchi Fabrizio  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 10, 2006-07 ,pp. : 1399-1407

Informa Healthcare

Access to resources Recommend Favorite